Mark Iwicki & Management Eval.

Quote



AHurtInvestor said:
So as an investor, I am here to ask for an honest evaluation from employees on Mark & his management. I would prefer it if fellow investors REFRAIN FROM POSTING SO WE CAN HAVE A BETTER INSIDE PERSPECTIVE ON WHAT IS GOING ON. Feel free to respond anonymously.
Click to expand...

It is a good thing that Kala got the United win but what investors don’t realize is that regardless of insurance coverage we have a copay assistance card that allows patients to pay $40 for commercial covered and $60 for not covered. The main issue is that doctors and there staff are overwhelmed with the amount prior authorizations, callbacks, and pharmacies not honoring the copay card. Also, we have zero Medicare coverage and no copay assistance for Medicare which is a huge percentage of Dry Eye patients. Those Medicare patients would have to pay out of pocket around $500. And the sample of Eysuvis is a 5ml bottle with a 2.8ml fill which is way to big and makes it so many patients never fill their prescription and just use the sample. Doctors love Eysuvis when they use it but they often stop using it because of all the hassles with getting prescriptions filled. There are so many other steroids and generics that are much easier to write. That is the difference that makes a doctor write 1 Eysuvis a month instead of 10. The last thing I will say is the prescription size is a 10ml bottle with an 8.3ml fill so many doctors have their patients us it twice a day instead of 4 times a day and stretch it out and that eats into refills. So, again the insurance wins are nice but they are not going to change the trajectory of this launch anytime soon!
 


anonymous said:
It is a good thing that Kala got the United win but what investors don’t realize is that regardless of insurance coverage we have a copay assistance card that allows patients to pay $40 for commercial covered and $60 for not covered. The main issue is that doctors and there staff are overwhelmed with the amount prior authorizations, callbacks, and pharmacies not honoring the copay card. Also, we have zero Medicare coverage and no copay assistance for Medicare which is a huge percentage of Dry Eye patients. Those Medicare patients would have to pay out of pocket around $500. And the sample of Eysuvis is a 5ml bottle with a 2.8ml fill which is way to big and makes it so many patients never fill their prescription and just use the sample. Doctors love Eysuvis when they use it but they often stop using it because of all the hassles with getting prescriptions filled. There are so many other steroids and generics that are much easier to write. That is the difference that makes a doctor write 1 Eysuvis a month instead of 10. The last thing I will say is the prescription size is a 10ml bottle with an 8.3ml fill so many doctors have their patients us it twice a day instead of 4 times a day and stretch it out and that eats into refills. So, again the insurance wins are nice but they are not going to change the trajectory of this launch anytime soon!
Click to expand...
I am invested in Kala. I don’t understand why there is talk of price when you have a better product than the competitors. When you have choices in anything the price reflects value. This is hard understand why you are getting so caught up over price?????
 


anonymous said:
I am invested in Kala. I don’t understand why there is talk of price when you have a better product than the competitors. When you have choices in anything the price reflects value. This is hard understand why you are getting so caught up over price?????
Click to expand...
Ok let's play a game. Let's say your doc writes you Eysuvis. You've never taken it but they say it's good. You get to Walgreens and they say it isn't covered by your insurance that it will be $500, are you paying that? Now let's say you remember they gave you a card so you hand it over but they tell you it didn't work what are you doing now?. Oh OK I'll be nice and let's say it did work and that it is $60.. Now days with all the crap going on $60 isn't just change for most people and they will ask for something cheaper. If they do get it and do get it filled everything the other person posted above is accurate. 2 fills a year isn't much and offices are CONSTANTLY jumping Through hoops to get prior authorizations approved for the pharmacist won’t let the patient use the card until the prior authorization has been approved so it is extremely annoying and time consuming. Do you get it now!?
 


anonymous said:
Ok let's play a game. Let's say your doc writes you Eysuvis. You've never taken it but they say it's good. You get to Walgreens and they say it isn't covered by your insurance that it will be $500, are you paying that? Now let's say you remember they gave you a card so you hand it over but they tell you it didn't work what are you doing now?. Oh OK I'll be nice and let's say it did work and that it is $60.. Now days with all the crap going on $60 isn't just change for most people and they will ask for something cheaper. If they do get it and do get it filled everything the other person posted above is accurate. 2 fills a year isn't much and offices are CONSTANTLY jumping Through hoops to get prior authorizations approved for the pharmacist won’t let the patient use the card until the prior authorization has been approved so it is extremely annoying and time consuming. Do you get it now!?
Click to expand...
$60 is not an unreasonable amount for a product that no one else has that compares to. I was told this product works extremely well so occasionally doing paperwork for a patient to get the best should be a no brainer. Doctors want to help patients and have taken a oath to do no harm.
 


anonymous said:
$60 is not an unreasonable amount for a product that no one else has that compares to. I was told this product works extremely well so occasionally doing paperwork for a patient to get the best should be a no brainer. Doctors want to help patients and have taken a oath to do no harm.
Click to expand...
In fact my Rheumatologist has a person that does that type of paperwork so other docs do too
 


anonymous said:
$60 is not an unreasonable amount for a product that no one else has that compares to. I was told this product works extremely well so occasionally doing paperwork for a patient to get the best should be a no brainer. Doctors want to help patients and have taken a oath to do no harm.
Click to expand...
you cannot be serious!? $60 is not unreasonable maybe for you, not every single person has the same thoughts on that. Every steroid works, on label or not. Lotemax $35 with coupon works, Flarex with a coupon works, whatever they all work, they all make your eyes feel good. Is ammplify unique, yes but cost is relative. Do no harm? Writing an off label steroid for dry eye isn't the tragedy you think it is.
 


anonymous said:
you cannot be serious!? $60 is not unreasonable maybe for you, not every single person has the same thoughts on that. Every steroid works, on label or not. Lotemax $35 with coupon works, Flarex with a coupon works, whatever they all work, they all make your eyes feel good. Is ammplify unique, yes but cost is relative. Do no harm? Writing an off label steroid for dry eye isn't the tragedy you think it is.
Click to expand...
The you are missing is the products you mentioned are not your product. They are different and of course have different price points but the best products demand a premium. The drug is supposed to be excellent. People on here say it is and it is different other products.
 


After thinking about it some more I realize now that you are right. Doctors have no right to be frustrated about their staff being inundated with prior authorizations and pharmacies and patients constantly calling back and saying that it is not covered or will cost $500 plus. I need to just tell them to find somebody that will do the prior auths for them just like your Rheumatologist, Psychologist, and Psychiatrist do.
 


anonymous said:
The you are missing is the products you mentioned are not your product. They are different and of course have different price points but the best products demand a premium. The drug is supposed to be excellent. People on here say it is and it is different other products.
Click to expand...
You're an idiot. I don’t care if it cures cancer it shouldn't be $500. The amount we charge for things in this country like Healthcare and pharmaceuticals is criminal.
 


anonymous said:
The you are missing is the products you mentioned are not your product. They are different and of course have different price points but the best products demand a premium. The drug is supposed to be excellent. People on here say it is and it is different other products.
Click to expand...
Loteprednol is an OLD DRUG. There is a generic and soon a generic gel formulation by Akorn. MMP technology is great in many offices is not worth the time, effort, and headache that it takes to get it get through the process and into patients hands.
We shot ourselves in the foot by making the sample WAY TO LARGE as well as the trade size bottle.
 


anonymous said:
Loteprednol is an OLD DRUG. There is a generic and soon a generic gel formulation by Akorn. MMP technology is great in many offices is not worth the time, effort, and headache that it takes to get it get through the process and into patients hands.
We shot ourselves in the foot by making the sample WAY TO LARGE as well as the trade size bottle.
Click to expand...
Wait if this is an old drug what differentiates it from the first $&@! Drug!! No wonder this investment is crashing!!!!
 










anonymous said:
Well why make that financial investment?? Is management attempting to clean up the mess that is talked about on here? I assume half of it is true but if only a quarter is the stock is going to take a while to recover if ever.
Click to expand...
Management from the top all the way down to the front line managers are completely inept.
 




anonymous said:
The you are missing is the products you mentioned are not your product. They are different and of course have different price points but the best products demand a premium. The drug is supposed to be excellent. People on here say it is and it is different other products.
Click to expand...


This person has to understand that Eyecare is like the Wild, Wild West….not monitored at all.

yes this product is OURs but Loteprednol is the foundation of it, and there are several Loteprednol options out there:
-Loteprednol Suspension (very old, Generic)
-Loteprednol Ointment
-Loteprednol Gel (Generic)
-Lotemax SM (Brand)
-Inveltys (Brand)
-Alrex (Brand, and low concentration Loteprednol)
-and also Eysuvis

So doctors don’t even care, many of these formulations have the same foundation and others have different formulations (suspensions, gels, ointments, etc)

Therefore cost and coverage ARE factors and doctors WILL get a similar product with similar benefits just writing a covered product.

I hate “investors” who don’t really know the industry—-if they really are an investor and not some home office troll playing stupid.

hey silly investor, why not pressure HQ to just hire Pam back if you know so much!!!!!!
 





Write your reply...
Top Bottom
Back
Quote